Literature DB >> 2324262

Assessment of the viability and pregnancy potential of mouse embryos biopsied at different preimplantation stages of development.

U B Krzyminska1, J Lutjen, C O'Neill.   

Abstract

The developmental potential in vitro and in vivo of preimplantation mouse embryos biopsied at the 4-cell, 8-cell and morula stages were investigated. Biopsy had the least impact when performed at the 8-cell stage. There was no effect of biopsy on the development of 8-cells of blastocysts in vitro (95% compared with 99% of controls) or the implantation rate after transfers (82 versus 87%, P greater than 0.05); however, fewer embryos (52 versus 71%, P less than 0.05) resulted in viable fetuses. There was no effect of biopsy at the 8-cell stage on fetal weight on day 17. Blastocyst formation in vitro was significantly less for 4-cell biopsies compared with their controls (76 versus 90%, P less than 0.001) and biopsy also affected the implantation rate (44 versus 59%, P less than 0.01). Biopsy was most detrimental when performed on morulae, reducing the implantation rate from 65% for controls to 21% for biopsies (P less than 0.001). Fetal viability was also markedly affected with a reduction on day 17 from 42 to 26% accompanied by a significant reduction (24%, P = 0.02) of the mean fetal weight. Handling of embryos for biopsy at the morula stage, which involved removal of the zona pellucida, was a significant but not complete cause of the reduced implantation potential observed (sham-controls and intact-controls: 34 and 65%, P less than 0.001), while puncture of the zona during the biopsy of 4-cell and 8-cell embryos had no effect. Therefore, the 8-cell mouse embryo is the most suitable state for embryo biopsy.

Entities:  

Mesh:

Year:  1990        PMID: 2324262     DOI: 10.1093/oxfordjournals.humrep.a137070

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Laser ablation of the mouse zona pellucida for blastomere biopsy.

Authors:  F Licciardi; A Gonzalez; Y X Tang; J Grifo; J Cohen; Y Neev
Journal:  J Assist Reprod Genet       Date:  1995-08       Impact factor: 3.412

Review 2.  Preimplantation diagnosis.

Authors:  J D Goldberg; M C Martin; R V Lebo; R A Pedersen
Journal:  West J Med       Date:  1993-09

3.  A simplified technique for embryo biopsy: use of the same micropipette for zona drilling and blastomere aspiration.

Authors:  S U Chen; H N Ho; H F Chen; K H Chao; S C Huang; T Y Lee; Y S Yang
Journal:  J Assist Reprod Genet       Date:  1997-03       Impact factor: 3.412

4.  Blastomere removal from cleavage-stage mouse embryos alters steroid metabolism during pregnancy.

Authors:  Atsushi Sugawara; Brittany Sato; Elise Bal; Abby C Collier; Monika A Ward
Journal:  Biol Reprod       Date:  2012-07-05       Impact factor: 4.285

5.  Hatching rate: an optimal discriminator for the assessment of single-blastomere biopsy.

Authors:  K H Cui; P J Verma; C D Matthews
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

6.  Outcomes of preimplantation genetic diagnosis using either zona drilling with acidified Tyrode's solution or partial zona dissection.

Authors:  Hyun Jung Kim; Chung Hyon Kim; Soo Min Lee; Seung Ah Choe; Joong Yeup Lee; Byung Chul Jee; Doyeong Hwang; Ki Chul Kim
Journal:  Clin Exp Reprod Med       Date:  2012-09-30

7.  The effect of biopsy during precompacted morula stage on post vitrification development of blastocyst derived bovine embryos.

Authors:  Abolfazl Shirazi; Sara Borjian; Ebrahim Ahmadi; Hassan Nazari; Banafsheh Heidari
Journal:  Avicenna J Med Biotechnol       Date:  2010-04

8.  Effects of Timing on Cell Biopsy from Pre-compacted Morula Stage Bovine Embryos on Subsequent Embryonic Development.

Authors:  Shirazi Abolfazl; Borjian Sara; Nazari Hassan; Ahmadi Ebrahim; Heidari Banafsheh; Bahiraee Amin
Journal:  J Reprod Infertil       Date:  2010-04

9.  Biopsy of human morula-stage embryos: outcome of 215 IVF/ICSI cycles with PGS.

Authors:  Elena E Zakharova; Victoria V Zaletova; Alexander S Krivokharchenko
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.